NCT01600755View on ClinicalTrials.gov

Autologous Cell Therapy for Treatment of Fecal Incontinence

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

March 28, 2013

Primary Completion Date

October 27, 2021

Study Completion Date

October 27, 2021

Conditions
Fecal Incontinence
Interventions
BIOLOGICAL

Iltamiocel

Single intrasphincteric injection of iltamiocel at a dose of 250 x 10\^6 cells

Trial Locations (2)

V6Z 1Y6

St. Paul's Hospital, Vancouver

Unknown

Royal London Hospital, London

Sponsors

Lead Sponsor

Cook MyoSite
All Listed Sponsors
lead

Cook MyoSite

INDUSTRY